In fact, meta-analysis of published microarray datasets [50, 51] revealed that increased TMEPAI and Smad3 expression and decreased Smad2 expression in lung and gastric cancers was significantly associated with poorer patient prognosis (Supplementary Figure 1 and Supplementary Figure 2). This evidence concerns the gene SMAD3 and gastric cancer.